首页> 外文期刊>Thrombosis >Rheolytic Thrombectomy with or without Adjunctive Indwelling Pharmacolysis in Patients Presenting with Acute Pulmonary Embolism Presenting with Right Heart Strain and/or Pulseless Electrical Activity
【24h】

Rheolytic Thrombectomy with or without Adjunctive Indwelling Pharmacolysis in Patients Presenting with Acute Pulmonary Embolism Presenting with Right Heart Strain and/or Pulseless Electrical Activity

机译:急性肺栓塞伴有右心劳损和/或无脉搏电活动的患者进行流式血栓切除术伴或不伴有辅助药物残留

获取原文
       

摘要

Purpose. To evaluate the safety and efficacy of the Possis rheolytic thrombectomy with or without indwelling catheter-directed pharmacolysis for the treatment of massive pulmonary embolus in patients presenting with right heart strain and/or a pulseless electrical activity (PEA).Materials and Methods. Retrospective review of patients undergoing pulmonary pharmacolysis was performed (07/2004–06/2009). Pre- and posttreatment Miller index scoring weres calculated and compared. Patients were evaluated for tPA doses, ICU stay, hospital stay, and survival by Kaplan-Meier analysis.Results. 11 patients with massive PE were found, with 10/11 presenting with a Miller score of >17 (range: 16–27, mean: 23.2). CTPA and/or echocardiographic evidence of right heart strain was found in 10/11 patients. 3 (27%) patients presented with a PEA event. Two (18%) patients had a contraindication to pharmacolysis and were treated with mechanical thrombectomy alone. The intraprocedural mortality was 9% (n=1/11). Of the 10 patients who survived the initial treatment, 7 patients underwent standard mechanical thrombectomy initially, while 5 received power pulse spray mechanical thrombectomy. Eight of these 10 patients underwent adjunctive indwelling catheter-directed thrombolysis. The mean catheter-directed infusion duration was 18 hours (range of 12–26 hours). The average intraprocedural, infusion, and total doses of tPA were 7 mg, 19.7 mg, and 26.7 mg, respectively. There was a 91% (10/11) technical success rate. The failure was the single mortality. Average reduction in Miller score was 9.5 or 41% (P=0.009), obstructive index of 6.4 or 47% (P=0.03), and perfusion index of 2.7 or 28% (P=0.05). Average ICU and hospital stay were 7.4 days (range 2–27 days) and 21.3 days (range 6–60 days), respectively. Intent to treat survival was 90% at 6, 12, and 18 months.Conclusion. Rheolytic thrombectomy with or without adjunctive catheter-directed thrombolysis provides a safe and effective method for treatment of acute PE in patients who present with right heart strain and/or a PEA event.
机译:目的。评估有或没有留置导尿管的药物治疗的Possis流式血栓切除术在患有右心劳损和/或无脉搏电活动(PEA)的患者中治疗大面积肺栓塞的安全性和有效性。材料和方法。对接受肺部药物溶解治疗的患者进行了回顾性审查(07 / 2004–06 / 2009)。计算并比较了治疗前后的米勒指数得分。通过Kaplan-Meier分析评估患者的tPA剂量,ICU住院时间,住院时间和生存率。发现11例大面积PE患者,其中10/11的Miller评分> 17(范围:16-27,平均:23.2)。在10/11患者中发现了右心脏劳损的CTPA和/或超声心动图证据。 3名(27%)患者出现了PEA事件。 2名(18%)患者有药物溶解禁忌症,仅接受机械血栓切除术治疗。术中死亡率为9%(n = 1/11)。在最初治疗中幸存的10例患者中,有7例最初接受了标准机械血栓切除术,而5例接受了动力脉冲喷雾机械血栓切除术。这10例患者中有8例接受了辅助留置导管定向溶栓治疗。导管定向输注的平均持续时间为18小时(范围为12-26小时)。 tPA的平均术中,输注和总剂量分别为7μmg,19.7μmg和26.7μmg。技术成功率为91%(10/11)。失败是唯一的死亡率。 Miller评分平均降低9.5或41%(P = 0.009),阻塞指数6.4或47%(P = 0.03),灌注指数2.7或28%(P = 0.05)。 ICU和住院平均时间分别为7.4天(2–27天)和21.3天(6–60天)。在6、12和18个月时生存率达90%。结论。伴或不伴导管辅助溶栓的流式血栓切除术为存在右心脏劳损和/或PEA事件的患者提供了一种安全有效的急性PE治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号